Rimonabant
Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)
Sanofi · Phase 3 · Terminated · Enrollment 915
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| 1 | Obesity or overweight | n/r | 52 | n/r | n/r |
| 2 | Obesity or overweight | n/r | 52 | n/r | n/r |